This location is an integrated R&D and manufacturing facility with administrative, commercial, research and production functions.
The 151,028 sq. ft. (14,031 m2) facility manufactures products using Eurand’s proprietary technologies and supplies products to markets worldwide, including the U.S. and Japan.
This approximately 45,650 sq. ft. (4,241 m2) manufacturing facility develops products using Eurand’s proprietary Diffucaps® and Eurand Minitabs® technologies.
Pharmaceutical technologies for formulation development and life cycle management solutions.
Click Now